Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.
作者信息
Jones Andrew M, Webb A Kevin
机构信息
Manchester Adult Cystic Fibrosis Centre, South Manchester University Hospitals NHS Trust, Southmoor Road, Manchester M23 9LT, UK.
出版信息
J R Soc Med. 2003;96 Suppl 43(Suppl 43):66-72.
Abstract
摘要
相似文献
1
Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.
J R Soc Med. 2003;96 Suppl 43(Suppl 43):66-72.
2
Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
J Cyst Fibros. 2004 Aug;3(3):159-63. doi: 10.1016/j.jcf.2004.03.010.
3
Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.
J R Soc Med. 2000;93 Suppl 38(Suppl 38):40-5.
4
Sequencing of the Pseudomonas aeruginosa and Burkholderia cepacia genomes and their applications in relation to cystic fibrosis.
J R Soc Med. 2003;96 Suppl 43(Suppl 43):57-65.
5
Bacterial contaminants in cosmetic products from a patient with cystic fibrosis.
Br J Biomed Sci. 2006;63(3):141-2. doi: 10.1080/09674845.2006.11978090.
6
Segregation is good for patients with cystic fibrosis.
J R Soc Med. 2008 Jul;101 Suppl 1(Suppl 1):S31-5. doi: 10.1258/jrsm.2008.s18007.
7
Efficacy of the biocide Steri-7 against the common Gram-negative bacterial pathogens (Burkholderia cenocepacia, Burkholderia gladioli, Burkholderia multivorans, Pseudomonas aeruginosa and Stenotrophomonas maltophilia) associated with cystic fibrosis (CF).
Br J Biomed Sci. 2013;70(2):80-1. doi: 10.1080/09674845.2013.11669940.
8
Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.
J Infect. 2000 Mar;40(2):164-70. doi: 10.1053/jinf.1999.0626.
9
Inhibition of co-colonizing cystic fibrosis-associated pathogens by Pseudomonas aeruginosa and Burkholderia multivorans.
Microbiology (Reading). 2014 Jul;160(Pt 7):1474-1487. doi: 10.1099/mic.0.074203-0. Epub 2014 Apr 30.
10
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
J Clin Microbiol. 1996 Apr;34(4):886-91. doi: 10.1128/jcm.34.4.886-891.1996.
引用本文的文献
1
NaCl-induced modulation of species distribution in a mixed / / biofilm.
Biofilm. 2023 Sep 4;6:100153. doi: 10.1016/j.bioflm.2023.100153. eCollection 2023 Dec 15.
2
Sepsis Due to Infection After Multiple Trauma in a Non-Cystic Fibrosis Patient: A Case Report from Southeast China.
Infect Drug Resist. 2022 Dec 2;15:7043-7052. doi: 10.2147/IDR.S388520. eCollection 2022.
3
Genome insights from the identification of a novel Pandoraea sputorum isolate and its characteristics.
PLoS One. 2022 Aug 5;17(8):e0272435. doi: 10.1371/journal.pone.0272435. eCollection 2022.
4
Burkholderia cepacia complex in cystic fibrosis in the post-epidemic period: multilocus sequence typing-based approach.
Folia Microbiol (Praha). 2017 Nov;62(6):509-514. doi: 10.1007/s12223-017-0523-x. Epub 2017 Mar 31.
5
Home versus hospital intravenous antibiotic therapy for cystic fibrosis.
Cochrane Database Syst Rev. 2015 Dec 15;2015(12):CD001917. doi: 10.1002/14651858.CD001917.pub4.
6
Pseudomonas aeruginosa infection among cystic fibrosis and ICU patients in the referral children medical hospital in Tehran, Iran.
J Prev Med Hyg. 2013 Mar;54(1):24-8.
7
A LuxR-type repressor of Burkholderia cenocepacia inhibits transcription via antiactivation and is inactivated by its cognate acylhomoserine lactone.
Mol Microbiol. 2013 Jan;87(1):94-111. doi: 10.1111/mmi.12085. Epub 2012 Nov 19.
8
Saturation mutagenesis of a CepR binding site as a means to identify new quorum-regulated promoters in Burkholderia cenocepacia.
Mol Microbiol. 2011 Feb;79(3):616-32. doi: 10.1111/j.1365-2958.2010.07469.x.
本文引用的文献
1
Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa.
Thorax. 2002 Nov;57(11):924-5. doi: 10.1136/thorax.57.11.924.
2
Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.
Am J Respir Crit Care Med. 2002 Oct 1;166(7):988-93. doi: 10.1164/rccm.2203011.
3
Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic.
Am J Respir Crit Care Med. 2002 Oct 1;166(7):983-7. doi: 10.1164/rccm.200204-269OC.
4
Psychological consequences of segregation resulting from chronic Burkholderia cepacia infection in adults with CF.
Thorax. 2002 Sep;57(9):756-8. doi: 10.1136/thorax.57.9.756.
5
An epidemic Burkholderia cepacia complex strain identified in soil.
Lancet. 2002 Jun 8;359(9322):2002-3. doi: 10.1016/S0140-6736(02)08836-0.
6
Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus.
Lancet Infect Dis. 2002 Mar;2(3):180-9. doi: 10.1016/s1473-3099(02)00227-x.
7
Can antibiotic-resistant nosocomial infections be controlled?
Lancet Infect Dis. 2001 Aug;1(1):38-45. doi: 10.1016/S1473-3099(01)00020-2.
8
Strategies for improving transition to adult cystic fibrosis care, based on patient and parent views.
Pediatr Pulmonol. 2001 Dec;32(6):428-36. doi: 10.1002/ppul.1154.
9
Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays.
J Clin Microbiol. 2001 Dec;39(12):4452-5. doi: 10.1128/JCM.39.12.4452-4455.2001.
10
Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
Clin Infect Dis. 2001 Nov 1;33(9):1469-75. doi: 10.1086/322684. Epub 2001 Oct 4.
Zotero 插件